Drug intelligence / Profile preview

ferrimanitol ovalbumin

Development stage
Phase 4
Lead developer
Italfarmaco
Modality
Recombinant Proteins and Enzymes
Administration
Oral
01

Overview

Ferrimanitol ovalbumin is an iron-protein complex consisting of trivalent iron (Fe³⁺) coordinated with mannitol and ovalbumin (the primary protein found in egg white). It is a pharmaceutical preparation specifically developed for the treatment of iron deficiency states and iron deficiency anemia. The complex is designed to remain stable and insoluble at the acidic pH of the stomach, which prevents the release of free iron ions that typically cause gastric mucosal irritation and side effects common with traditional ferrous salts. Upon entering the alkaline environment of the duodenum and jejunum, the complex releases iron in a controlled manner for absorption. This pharmacokinetic profile results in significantly improved gastrointestinal tolerability while maintaining high bioavailability for the restoration of systemic iron levels.

Brand names
KenergonProferSolferFerro-Profer
Other names
Ferrimannitol ovalbuminIron mannitol ovalbumin complexFerrimanitol ovalbumina

Beyond the preview

Go deeper on ferrimanitol ovalbumin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ferrimanitol ovalbumin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call